Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.83 - $1.18 $945 - $1,344
-1,139 Reduced 9.24%
11,183 $12,000
Q1 2023

May 09, 2023

SELL
$0.8 - $4.98 $11,423 - $71,109
-14,279 Reduced 53.68%
12,322 $10,000
Q4 2022

Feb 10, 2023

BUY
$1.88 - $36.45 $17,970 - $348,425
9,559 Added 56.09%
26,601 $63,000
Q3 2022

Nov 10, 2022

BUY
$2.5 - $37.95 $7,900 - $119,922
3,160 Added 22.76%
17,042 $39,000
Q2 2022

Aug 15, 2022

BUY
$1.75 - $11.34 $16,049 - $103,999
9,171 Added 194.67%
13,882 $34,000
Q1 2022

May 12, 2022

BUY
$10.21 - $20.29 $34,622 - $68,803
3,391 Added 256.89%
4,711 $48,000
Q4 2021

Feb 14, 2022

BUY
$16.76 - $22.99 $3,000 - $4,115
179 Added 15.69%
1,320 $26,000
Q3 2021

Nov 15, 2021

SELL
$13.15 - $22.56 $41,409 - $71,041
-3,149 Reduced 73.4%
1,141 $21,000
Q2 2021

Aug 16, 2021

BUY
$18.28 - $33.05 $59,391 - $107,379
3,249 Added 312.1%
4,290 $78,000
Q1 2021

May 17, 2021

BUY
$29.34 - $60.2 $19,687 - $40,394
671 Added 181.35%
1,041 $34,000
Q4 2020

Feb 16, 2021

BUY
$27.25 - $55.82 $10,082 - $20,653
370 New
370 $20,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0

About Praxis Precision Medicines, Inc.


  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $3.54B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.